The Value of Direct Patient Reporting in Pharmacovigilance

Overview

Journal Ther Adv Drug Saf

Publisher Sage Publications

Date 2022 Feb 17

PMID 35173952

Authors

Kruger Paola

Gasperini Claudio

Affiliations

Soon will be listed here.

Citing Articles

Adverse Events Reporting in Digital Interventions Evaluations for Psychosis: A Systematic Literature Search and Individual Level Content Analysis of Adverse Event Reports.

Allan S, Ward T, Eisner E, Bell I, Cella M, Chaudhry I Schizophr Bull. 2024; 50(6):1436-1455.

PMID: 38581410 PMC: 11548921. DOI: 10.1093/schbul/sbae031.

Detection of potential safety signals related to the use of remdesivir and tocilizumab in the COVID era during pregnancy, resorting to open data from the FDA adverse event reporting system (FAERS).

Romao B, Duval F, Lima E, Silva F, de Matos G Front Pharmacol. 2024; 15:1349543.

PMID: 38370482 PMC: 10870234. DOI: 10.3389/fphar.2024.1349543.

Promoting Collaboration of Regulators and Patients in Improving Drug Safety and Regulatory Decision Making.

Khoo Y, Lim J, Tan-Koi W, Kitikiti N, Sim-Devadas A Drug Saf. 2023; 47(3):217-225.

PMID: 38082120 DOI: 10.1007/s40264-023-01385-2.

Jordanians' knowledge, attitude and practice regarding adverse drug reactions reporting.

El-Dahiyat F, Hammour K, Farha R, Manaseer Q, Al Momanee A, Allan A Saudi Pharm J. 2023; 31(7):1197-1201.

PMID: 37273263 PMC: 10236368. DOI: 10.1016/j.jsps.2023.05.016.

Awareness, Actions, and Predictors of Actions on Adverse Drug Reaction Reporting among Patients Attending a Referral Hospital in Southern Highland Tanzania.

Sirili N, Kilonzi M, Mwakawanga D, Mohamedi J, Thobias J, Clement A Adv Pharmacol Pharm Sci. 2023; 2023:7761649.

PMID: 37200768 PMC: 10188260. DOI: 10.1155/2023/7761649.

References

Defer G, Le Caignec F, Fedrizzi S, Montastruc F, Chevanne D, Parienti J . Dedicated mobile application for drug adverse reaction reporting by patients with relapsing remitting multiple sclerosis (Vigip-SEP study): study protocol for a randomized controlled trial. Trials. 2018; 19(1):174. PMC: 5845183. DOI: 10.1186/s13063-018-2560-4. View

Kieffer C, Reisin Miller A, Chacko B, Robertson A . FDA Reported Use of Patient Experience Data in 2018 Drug Approvals. Ther Innov Regul Sci. 2020; 54(3):709-716. DOI: 10.1007/s43441-019-00106-1. View

van Hunsel F, Harmark L, Rolfes L . Fifteen years of patient reporting -what have we learned and where are we heading to?. Expert Opin Drug Saf. 2019; 18(6):477-484. DOI: 10.1080/14740338.2019.1613373. View

Matos C, Harmark L, van Hunsel F . Patient Reporting of Adverse Drug Reactions: An International Survey of National Competent Authorities' Views and Needs. Drug Saf. 2016; 39(11):1105-1116. DOI: 10.1007/s40264-016-0453-6. View

van Stekelenborg J, Ellenius J, Maskell S, Bergvall T, Caster O, Dasgupta N . Recommendations for the Use of Social Media in Pharmacovigilance: Lessons from IMI WEB-RADR. Drug Saf. 2019; 42(12):1393-1407. PMC: 6858385. DOI: 10.1007/s40264-019-00858-7. View